Myra van Linde

Research output

Research output per year 2010 2021 2022 2023

• 25 Article
• 7 Meeting Abstract
• 3 Review article
• 1 Letter
• 1 More
  • 1 Phd-Thesis - Research and graduation internal

Research output per year

Research output per year

Search results

• 2021

  ABSENCE OF SEVERE HEMATOLOGICAL TOXICITY DURING FIRST LINE TREATMENT PREDICTS LOW CHANCE ON SEVERE TOXICITY DURING SECOND LINE ALKYLATING CHEMOTHERAPY IN GLIOBLASTOMA

  van den Elzen, F. E. L., Grun, N., Osinga, J., van der Vegt, A. N., de Glopper, L., Sintemaartensdijk, M., van Linde, M. E., Postma, T. J., Schuur, M. & Kouwenhoven, M. C. M., Sept 2021, In: Neuro-Oncology. 23, p. 8-8

  Research output: Contribution to journal › Meeting Abstract › Academic

• P12.02 Symptoms of patients with diffuse glioma during stable disease as a potential target for treatment

  Röttgering, JG., Belgers, V., Kouwenhoven, MCM., Schuur, M., Postma, TJ., Nijboer, C. M., van Linde, ME., Versélewel de Witt Hamer, PC., Douw, L. & Klein, M., 2021, In: Neuro-Oncology.

  Research output: Contribution to journal › Meeting Abstract › Academic

  Open Access

• P12.07 The potential of cannabinoids to improve quality of life in glioma patients: A meta-analysis in patients with neurological and oncological disease

  Belgers, V., Röttgering, JG., Douw, L., Klein, M., van de Ven, PM., Ket, J. C. F., Svendsen, K. B., Weber, M., Lopez-Sendon, J. L., Rikkert, M. O., Chagas, M. H. N., van Linde, ME., Kouwenhoven, MCM. & Versélewel de Witt Hamer, PC., 2021, In: Neuro-Oncology.

  Research output: Contribution to journal › Meeting Abstract › Academic

  Open Access

• P14.51 Can patients with a suspected high-grade glioma receive tumor treatment during pregnancy safely?

  Van der Vegt, A. N., de Vries, R., Osinga, J., Grun, N., Postma, T. J., de Haan, P. F., van Linde, M. E., Vandertop, W. P., Schuur, M. & Kouwenhoven, M. C. M., Sept 2021, In: Neuro-Oncology. 23, p. 47-47

  Research output: Contribution to journal › Meeting Abstract › Academic

• SEVERE HEMATOLOGICAL TOXICITY DURING CHEMORADIATION FOR GLIOBLASTOMA: IDENTIFICATION OF CLINICAL AND PHARMACOLOGICAL RISK FACTORS AND CONSEQUENCES FOR THE INDIVIDUAL PATIENT

  Grun, N., den Otter, C. A., Sintemaartensdijk, M., Osinga, J., van den Elzen, F. E. L., van der Vegt, A. N., de Haan, J., Bruynzeel, A. M. E., van Linde, M. E., Postma, T. J., Schuur, M., Hamer, P. C. D. W., De Vos, F. Y. F. L., Verhoeff, J. J. C., Jongen, J. L. M., Lissenberg-Witte, B. I. & Kouwenhoven, M. C. M., Sept 2021, In: Neuro-Oncology. 23, p. 40-40

  Research output: Contribution to journal › Meeting Abstract › Academic

• SYMPTOMS OF PATIENTS WITH DIFFUSE GLIOMA DURING STABLE DISEASE AS A POTENTIAL TARGET FOR TREATMENT

  Rottgering, J. G., Belgers, V., Kouwenhoven, M. C. M., Schuur, M., Postma, T. J., Nijboer, C. M., van Linde, M. E., Hamer, P. D. W., Douw, L. & Klein, M., Sept 2021, In: Neuro-Oncology. 23, p. 30-31

  Research output: Contribution to journal › Meeting Abstract › Academic

• THE POTENTIAL OF CANNABINOIDS TO IMPROVE QUALITY OF LIFE IN GLIOMA PATIENTS: A META-ANALYSIS IN PATIENTS WITH NEUROLOGICAL AND ONCOLOGICAL DISEASE

  Belgers, V., Rottgering, J. G., Douw, L., Klein, M., van de Ven, P. M., Ket, J. C. F., Svendsen, K. B., Weber, M., Lopez-Sendon, J., Rikkert, M. G. O., Chagas, M. H. N., van Linde, M. E., Kouwenhoven, M. C. M. & Hamer, P. C. D. W., Sept 2021, In: Neuro-Oncology. 23, p. 32-32

  Research output: Contribution to journal › Meeting Abstract › Academic